PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt

A Saavedra1, J M García-Martínez, X Xifró

  • 1Departament de Biologia Cellular, Immunologia i Neurociències, Facultat de Medicina, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Casanova 143, Barcelona, Spain.

Insights

Mutant huntingtin lowers PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) levels, affecting Akt activation in Huntington's disease (HD) models. This downregulation may protect neurons by maintaining Akt activity, even after mutant huntingtin silencing.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Huntington's disease (HD) pathophysiology involves gene expression dysregulation.
  • Mutant huntingtin (mHTT) is implicated in HD pathogenesis.
  • PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) dephosphorylates and inactivates Akt at Ser473.

Purpose of the Study:

  • To investigate the regulation of PHLPP1 by mutant huntingtin.
  • To determine the impact of PHLPP1 levels on Akt activation in HD.

Main Methods:

  • Analysis of PHLPP1 protein and mRNA levels in HD mouse models (knock-in and transgenic) and HD patient samples.
  • Quantitative PCR to assess PHLPP1 mRNA expression.
  • Western blot analysis to measure phosphorylated Akt (Ser473) levels.
  • Investigation using a conditional Tet/HD94 mouse model to observe PHLPP1 and Akt levels after mHTT shutdown.

Main Results:

  • Decreased PHLPP1 protein and mRNA levels were observed in the striatum of various HD models and in HD patient putamen.
  • Increased phosphorylated Akt (Ser473) levels were detected in the striatum of HD models.
  • In the Tet/HD94 model, PHLPP1 levels recovered to wild-type levels after mHTT shutdown, while phospho-Akt levels partially decreased.

Conclusions:

  • Mutant huntingtin downregulates PHLPP1 expression.
  • Reduced PHLPP1 in the striatum contributes to sustained Akt activation in HD.
  • Sustained Akt activation may offer neuroprotection and promote neuronal recovery after mHTT silencing.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...